Thomson X – the digital arm of Thomson Medical Group (TMG) – recently announced a joint venture (JV) with telehealth provider WhiteCoat. Following WhiteCoat’s S$10.8 million Series A funding round led by Golden Equator Ventures and Korea Investment Partners (via the GEC-KIP Technology and Innovation Fund) in 2021, he JV will enable WhiteCoat to capture a more sustainable area of growth, and provide better value for its consumer base. Furthermore, the JV will enable doctors under TMG to cater to a wider patient base. In the year ahead, the JV will also see WhiteCoat launch a mobile application offering online-to-offline healthcare services that meet the health and wellness needs of women and children.
Read the full article here.